Advance in Recovery

Advance in Recovery, based in Carrington, ND, is one of the SAMHSA-registered treatment programs operating in ND. The facility's programming is outpatient (Outpatient, Dual Dx), not residential. What this page can help with is the frame — what to ask, what to verify, what to compare against.

Care levels at Advance in Recovery

The care-level question matters because what a facility offers is what it can realistically treat well. Advance in Recovery is an outpatient-focused program (Outpatient, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. Before admission, an independent clinical assessment (from a primary-care doctor, licensed substance-use counselor, or addiction-medicine physician) can confirm whether Advance in Recovery's offerings match the clinical need.

Insurance and payment

Advance in Recovery accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The single most useful pre-admission move on insurance is requesting the facility send you — in writing, by email — the specific benefits verification for your specific plan product. That document is the answer to most post-admission billing disputes.

Before you call

Before admission to Advance in Recovery, three questions consistently produce the most useful information: (1) which ASAM level of care are you treating me at, and what is the clinical rationale; (2) can you send me a written Verification of Benefits for my specific insurance plan; (3) what is your policy on medication-assisted treatment for opioid use disorder — specifically, do you continue patients on buprenorphine or methadone during residential programming. If the clinical situation involves opioid use disorder, confirm explicitly whether Advance in Recovery offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.